Examples for such markers/targets, in the case of breast cancer, are the oestrogen receptor (ER), progesterone receptor (PgR), and the Erb2/Her2 molecule, a receptor tyrosine protein kinase that is overexpressed in a subset of breast cancers. There are number of treatment options for tumours that express the ER, PgR or Her2 receptors, however up to 20 percent of the newly diagnosed cases belong to a subset, which is negative for all three of the receptor molecules. This presentation will discuss applications of high-resolution hybrid mass spectrometry for quantitative genome-scale studies of protein abundance and post-translational modifications. The current state-of-the-art technology for large-scale proteome analysis of individual solid tumours is discussed. Case studies from experiments with triple-negative breast and colorectal tumours illustrating the capability of the proteome-based strategies are presented, as well as mechanistic investigations in cultured cells that have been informed by tumour proteomics and focus on specific phosphorylation hotspots and protein interactions of the tumour suppressor Scribble.
Genome-Scale Protein Expression Analysis of Individual Solid Tumors
Video May 12, 2015
Our genetic makeup has fascinated scientists and medical researchers for decades. There have been significant advances in the field of rewriting the blueprint of life or our DNA. It's been used to treat and prevent a number of disorders and diseases. But it could also be used to create what some have called 'designer babies'. The medical world is divided over the approach. Last year, a scientist in China said he created the world's first genetically edited twins -- leading to global condemnation. Scientists have gathered in Geneva this week to try come up with some regulations. But how would officials enforce rules around our DNA? And what are the risks of advanced research into human genetics?WATCH NOW
A breakthrough called CRISPR has given us unprecedented control over the basic building blocks of life. It opens the door to curing diseases, reshaping the biosphere, and designing our own children. Human Nature is a provocative exploration of CRISPR’s far-reaching implications, through the eyes of the scientists who discovered it, the families it’s affecting, and the bioengineers who are testing its limits. How will this new power change our relationship with nature? What will it mean for human evolution? To begin to answer these questions we must look back billions of years and peer into an uncertain future.WATCH NOW